Coronary, peripheral and cerebrovascular disease: A complex relationship

Herz

Volumn 33, Issue 7, 2008, Pages 475-480

  Shah, Amber M ^a   Banerjee, Teesta ^b   Mukherjee, Debabrata ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Cerebrovascular disease; Coronary artery disease; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORBOFIBAN;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE REGISTRY; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; OUTCOME ASSESSMENT; PATHOGENESIS; PRIMARY MEDICAL CARE; PROGNOSIS; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; TRANSIENT ISCHEMIC ATTACK;

CAUSALITY; CEREBROVASCULAR DISORDERS; COMORBIDITY; CORONARY ARTERY DISEASE; HUMANS; INCIDENCE; PERIPHERAL VASCULAR DISEASES; RISK ASSESSMENT; RISK FACTORS;

EID: 58049175873     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-008-3152-y     Document Type: Review

References (48)

1. Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-90.
2. Holman RL, McGill HC Jr, Strong JP, et al. The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the of the 20th century. Am J Pathol 1958;34:209-35.
3. Strong JP, Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young. JAMA 1986;256:2863-6.
4. Ross R, Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
5. Fruchart JC, Nierman MC, Stroes ES, et al. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109:Suppl 1:III15-9.
6. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75.
7. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
8. Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation 1990;82:1230-42.
9. Kallikazaros I, Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke 1999;30:1002-7.
10. Love BB, Grover-McKay M, Biller J, et al. Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke 1992;23:939-45.
11. Seo WK, Yong HS, Koh SB, et al. Correlation of coronary artery atherosclerosis with atherosclerosis of the intracranial cerebral artery and the extracranial carotid artery. Eur Neurol 2008;59:292-8.
12. Purroy F, Oro M, Quilez A, et al. [Detection of silent peripheral arterial disease in stroke patients with a low ankle-arm index.] Neurologia 2008;23:10-4.
13. Poredos P, Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 2007;58:309-15.
14. Golomb BA, Dang TT, Criqui MH, Peripheral arterial disease: morbidity and mortality implications. Circulation 2006;114:688-99.
15. Tierney S, Fennessy F, Hayes DB. ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 2000;320:1262-5.
16. Pilcher JM, Danaher J, Khaw KT. The prevalence of asymptomatic carotid artery disease in patients with peripheral vascular disease. Clin Radiol 2000;55:56-61.
17. Cheng SW, Wu LL, Lau H, et al. Prevalence of significant carotid stenosis in Chinese patients with peripheral and coronary artery disease. Aust N Z J Surg 1999;69:44-7.
18. Kurvers HA, van der Graaf Y, Blankensteijn JD, et al. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta: comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only. J Vasc Surg 2003; 37: 1226-33.
19. Dieter RS, Tomasson J, Gudjonsson T, Brown RL, et al. Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease. Vasc Med 2003;8:233-6.
20. Tanimoto S, Ikari Y, Tanabe K, et al. Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke 2005;36:2094-8.
21. Cotter G, Cannon CP, McCabe CH, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 2003;145:622-7.
22. Dhamoon MS, Tai W, Boden-Albala B, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan study. Stroke 2007;38:1752-8.
23. Dhamoon MS, Sciacca RR, Rundek T, et al. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan study. Neurology 2006;66:641-6.
24. Atanassova PA, Chalakova NT, Dimitrov BD. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics. Cerebrovasc Dis 2008;25:225-33.
25. Eagle KA, Rihal CS, Foster ED, et al. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol 1994;23:1091-5.
26. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
27. Mukherjee D, Eagle KA, Smith DE, et al. Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]). Am J Cardiol 2003;92:972-4.
28. Mukherjee D, Eagle KA, Kline-Rogers E, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007;100:1-6.
29. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206.
30. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9.
31. De Caterina R, Libby P. Endothelial dysfunctions and vascular disease. Malden: Blackwell Futura, 2007.
32. Jain D, Shaker SM, Burg M, et al. Effects of mental stress on left ventricular and peripheral vascular performance in patients with coronary artery disease. J Am Coll Cardiol 1998;31:1314-22.
33. Pasqualini L, Marchesi S, Vaudo G, et al. Association between endothelial dysfunction and major cardiovascular events in peripheral arterial disease. Vasa 2003;32:139-43.
34. Aung PP, Maxwell HG, Jepson RG, et al. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007;4:CD000123.
35. Vergouwen MD, de Haan RJ, Vermeulen M, et al. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008;39:497-502.
36. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. BMJ 2002;324:71-86.
37. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
38. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 2004;292:1867-74.
39. Mukherjee D, Lingam P, Chetcuti S, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 2002;106:1909-12.
40. West JA, Cost-effective strategies for the management of vascular disease. Vasc Med 1997;2:25-9.
41. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172:95-105.
42. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
43. McDermott MM, Mehta S, Ahn H, et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15.
44. Cournot M, Cambou JP, Ferrieres J, et al. Management of the cardiology patient with polyvascular disease: PRISMA study. Arch Mal Coeur Vaiss 2004;97:841-8.
45. Atmer B, Jogestrand T, Laska J, et al. Peripheral artery disease in patients with coronary artery disease. Int Angiol 1995;14:89-93.
46. Simons PC, Algra A, Eikelboom BC, et al. Carotid artery stenosis in patients with peripheral arterial disease: the SMART study. SMART Study Group. J Vasc Surg 1999;30:519-25.
47. House AK, Bell R, House J, et al. Asymptomatic carotid artery stenosis associated with peripheral vascular disease: a prospective study. Cardiovasc Surg 1999;7:44-9.
48. Hoshino A, Nakamura T, Enomoto S, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction. Circ J 2008;72:404-8.